Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

NCT00800605 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7250

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Vero cell-derived, trivalent, seasonal influenza vaccine
BIOLOGICAL: Placebo: Phosphate-buffered saline

Sponsor

Alachua Government Services, Inc.